BAILEY FORD: Open Payments
NPI 1518322650 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 21 payments from 8 companies in 2025. Trend: 2023 $1,108 · 2024 $662 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $208 |
| Novo Nordisk Inc | 5 | $83 |
| Lilly USA, LLC | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| PFIZER INC. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| ABBVIE INC. | 1 | $17 |
Products named: FARXIGA, MOUNJARO, BREZTRI, Ozempic, CAPLYTA, Rybelsus, ELIQUIS, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
